1071 related articles for article (PubMed ID: 19966075)
1. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
Kirschenbaum BE
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
[TBL] [Abstract][Full Text] [Related]
2. Risk evaluation and mitigation strategies: impact on patients, health care providers, and health systems.
Shane R
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S6-S12. PubMed ID: 19966079
[TBL] [Abstract][Full Text] [Related]
3. The Food and Drug Administration Amendments Act of 2007: drug safety and health-system pharmacy implications.
Meyer BM
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S3-5. PubMed ID: 19966078
[TBL] [Abstract][Full Text] [Related]
4. Report of the ASHP Task Force on Caring for Patients Served by Specialty Suppliers.
Caselnova D; Donley K; Ehlers D; Hyduk AE; Koontz SE; Nowobilski-Vasilios A; Pawlicki KS; Poikonen JC; Poremba AC; Sasser CL; Schell KH; Schwab JL; Swinarski D; Chen D; Kirschenbaum B; Armitstead J
Am J Health Syst Pharm; 2010 Oct; 67(19):1650-8. PubMed ID: 20852168
[TBL] [Abstract][Full Text] [Related]
5. Specialty pharmacy cost management strategies of private health care payers.
Stern D; Reissman D
J Manag Care Pharm; 2006; 12(9):736-44. PubMed ID: 17249906
[TBL] [Abstract][Full Text] [Related]
6. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.
Stubbings J; Joshi RA; Hoffman JM
Am J Health Syst Pharm; 2010 Sep; 67(18):1547-54. PubMed ID: 20811034
[No Abstract] [Full Text] [Related]
7. Current issues in pharmaceutical reimbursement.
Fijalka S; Fye D; Johnson PE
Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243
[TBL] [Abstract][Full Text] [Related]
8. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
[TBL] [Abstract][Full Text] [Related]
9. APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation.
American Pharmacists Association ; Bough M
J Am Pharm Assoc (2003); 2011; 51(3):340-58. PubMed ID: 21555285
[TBL] [Abstract][Full Text] [Related]
10. Limited options to manage specialty drug spending.
Tu HT; Samuel DR
Res Brief; 2012 Apr; (22):1-13. PubMed ID: 23155549
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
12. Managing the intersection of medical and pharmacy benefits.
McDonald RC
J Manag Care Pharm; 2008 May; 14(4 Suppl):S7-11. PubMed ID: 18507508
[TBL] [Abstract][Full Text] [Related]
13. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
Bagwell A; Kelley T; Carver A; Lee JB; Newman B
J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
[TBL] [Abstract][Full Text] [Related]
14. A model for a drug distribution system in remote Australia as a social determinant of health using event structure analysis.
Rovers JP; Mages MD
BMC Health Serv Res; 2017 Sep; 17(1):677. PubMed ID: 28946918
[TBL] [Abstract][Full Text] [Related]
15. Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
Matthews ML
J Am Pharm Assoc (2003); 2013; 53(1):e1-7. PubMed ID: 23636166
[TBL] [Abstract][Full Text] [Related]
16. Estimated cost savings associated with the transfer of office-administered specialty pharmaceuticals to a specialty pharmacy provider in a Medical Injectable Drug program.
Baldini CG; Culley EJ
J Manag Care Pharm; 2011; 17(1):51-9. PubMed ID: 21204590
[TBL] [Abstract][Full Text] [Related]
17. [Alternatives to pharmaceutical distribution and reimbursement].
Meneu R
Gac Sanit; 2002; 16(2):171-81. PubMed ID: 11958754
[TBL] [Abstract][Full Text] [Related]
18. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
Wang J; Hong SH; Meng S; Brown LM
Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
[TBL] [Abstract][Full Text] [Related]
19. Comparing patient access to pharmaceuticals in the UK and US.
Cohen J; Cairns C; Paquette C; Faden L
Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
[TBL] [Abstract][Full Text] [Related]
20. Specialty pharmaceuticals care management in an integrated health care delivery system with electronic health records.
Monroe CD; Chin KY
J Manag Care Pharm; 2013 May; 19(4):334-44. PubMed ID: 23627579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
